Everything You Need to Know About Non-Specialty Pipeline between 10/2009 to 3/2010

[diana.papshev]

DETAILS:

Please click on the product name to view up-to-date details captured by DrugPipelineForecast

Cardiovascular:
Expected approvals in 4Q 2009

o Sympres XR

Expected approvals in 1Q 2010

o Certriad

CNS:
Expected approvals in 4Q 2009

o Acetavance
o Exalgo
o Intermezzo - FDA rejects drug 10/09 and unlikely to be approved before 2011
o Sprix
o Pennsaid - FDA approved 11/09
o Silenor - FDA rejects drug for 2nd time 12/09
o Solzira

Expected approvals in 1Q 2010

o CPI-300
o OxyContin (reformulated)
o trazodone

Endocrine/diabetes:
Expected approvals in 4Q 2009

o estradiol valerate/dienogest
o Nebido
o toremifene
o Victoza

Expected approvals in 1Q 2010

o Afresa
o Fortesta

GI:
Expected approvals in 4Q 2009

o Zegerid

Expected approvals in 1Q 2010

o Axanum
o ondansetron
o Vimovo

Expected approvals in 1Q 2010

o granisetron

Hematologics:
Expected approvals in 4Q 2009

o Lysteda (tranexamic acid)- FDA approved 11/09

Respiratory:
Expected approvals in 4Q 2009

o Mucinex with codeine

Expected approvals in 1Q 2010

o mometasone/formoterol

Topicals:
Expected approvals in 4Q 2009

o Qutenza - FDA approved 11/09

Latest updates are captured in the Non-Specialty Pipeline Forecast as of September 2009

For more information, longer-term pipeline, or to search for additional drugs, please see DrugPipelineForecast.

About DrugPipelineForecast:
DrugPipelineForecast is a tool developed specifically for managed care professionals to address their unique needs. This is a site which can help you track late-phase pipeline:

o Products in late phase III to approval stages
o All types of information for an in-depth review
o Tabulated format for a quick analysis
o Search and filtering capabilities
o Default and customized reports
o Frequent updates

To access DrugPipelineForecast at no charge (for those who are currently employed by a health plan, PBM, specialty pharmacy, IPA, employer/benefits consultant), you must be a registered user of DrugManagementForum (click here to register)

About DrugManagementForum:
DrugManagementForum is dedicated to the managed care pharmacy and medical policy community, allowing you to connect and share your ideas and solutions to common problems and experiences. It offers a place for users and experts to post questions and comments that are relevant to your practice in the managed care setting.

Benefits of registering with DrugManagementForum:

o Offers managed care professionals to connect and share ideas/solutions to common problems and experiences in drug benefit management
o Objective, unbiased content without a commercial agenda (no pharma sponsorship)
o Exclusive only for those who are currently employed by a health plan, PBM, specialty pharmacy, IPA, employer/benefits consultant, or another organization that is responsible for managing healthcare coverage (those in academia and benefit consulting can also join)
o Free and includes access to the DrugPipelineForecast
o Anonymity is guaranteed (if preferred), see the rules for more details